GeneDx Holdings Corp.
WGS · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$52,286 | -$175,767 | -$548,980 | -$245,390 |
| Dep. & Amort. | $21,953 | $35,834 | $59,309 | $21,807 |
| Deferred Tax | -$343 | -$926 | -$49,124 | $0 |
| Stock-Based Comp. | $9,138 | -$326 | $41,975 | $219,421 |
| Change in WC | -$24,745 | -$38,241 | $36,131 | $8,078 |
| Other Non-Cash | $17,787 | -$721 | $141,534 | -$194,350 |
| Operating Cash Flow | -$28,496 | -$180,147 | -$319,155 | -$190,434 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$5,491 | -$5,711 | -$14,322 | -$9,400 |
| Net Acquisitions | $0 | -$8,110 | -$127,004 | $0 |
| Inv. Purchases | -$66,302 | -$47,670 | $0 | $0 |
| Inv. Sales/Matur. | $41,661 | $17,765 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | -$11,386 |
| Investing Cash Flow | -$30,132 | -$43,726 | -$141,326 | -$20,786 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$3,225 | $42,951 | -$3,292 | -$13,469 |
| Stock Issued | $46,496 | $143,002 | $197,659 | $442,684 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $891 | $285 | $2,948 | $64,514 |
| Financing Cash Flow | $44,162 | $186,238 | $197,315 | $493,729 |
| Forex Effect | $0 | -$87 | $0 | $0 |
| Net Chg. in Cash | -$14,466 | -$37,722 | -$263,166 | $282,509 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $100,668 | $137,403 | $401,469 | $118,960 |
| End Cash | $86,202 | $99,681 | $138,303 | $401,469 |
| Free Cash Flow | -$33,987 | -$185,858 | -$333,477 | -$211,220 |